What is MapLight Therapeutics, Inc. Common Stock (MPLT) stock price today?

MapLight Therapeutics, Inc. Common Stock (MPLT) currently trades at $30.70 per share. The stock has a market capitalization of $1.30B and a P/E ratio of —x.

Is MPLT stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, MapLight Therapeutics, Inc. Common Stock has a Smart Value Score of 27/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

MPLT

MapLight Therapeutics, Inc. Common Stock

NASDAQ: MPLT · HEALTHCARE · BIOTECHNOLOGY

$30.70

-3.67% today

Updated 2026-05-01

Market cap

$1.30B

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-18.56

Dividend yield

—

52W range

$12 – $33

Volume

0.3M

Market cap

$1.30B

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-18.56

Dividend yield

—

52W range

$12 – $33

Volume

0.3M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

5.0

Quality

C+

3.0

Profitability

5.0

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →204 stocks currently score above 75

Price targets

Analyst target

$32.67

+6.42%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

1 Strong Buy4 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

Insufficient data

Risks

- Thin margins at 0.00%

- Negative free cash flow $-47.20M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	—	—	—	$0.00	$0.00
Net income	$-30.02M	$-55.71M	$-77.58M	$-161.15M	$-79.55M
EPS	—	—	—	—	$-18.56
Free cash flow	$-27.32M	$-52.47M	$-79.58M	$-138.61M	$-47.20M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
MPLT	$1.30B	27	4.3	3.0	5.0	5.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-41.61%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-26.29%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.35%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

MapLight Therapeutics, Inc. Common Stock trades at $30.70. Our Smart Value Score of 27/100 indicates the stock is weak.

Frequently asked questions

What is MapLight Therapeutics, Inc. Common Stock's stock price?

MapLight Therapeutics, Inc. Common Stock (MPLT) trades at $30.70.

Is MapLight Therapeutics, Inc. Common Stock overvalued?

Smart Value Score 27/100 (Grade F, Strong Sell).

What is the price target of MapLight Therapeutics, Inc. Common Stock (MPLT)?

The analyst target price is $32.67, representing +6.4% upside from the current price of $30.70.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio—

ROE-56.20%

Beta—

50D MA$21.31

200D MA$18.78

Shares out0.04B

Float0.01B

Short ratio—

Avg volume0.3M

Performance

1 week+8.55%

1 month+14.25%

3 months+40.78%

YTD+28.72%

1 year—

3 years—

5 years—

Compare

MPLT vs LLY →MPLT vs JNJ →MPLT vs ABBV →Stock screener →